Variant report

Variant	nsv960465
Chromosome Location	chr17:33891831-33894995
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr17:33894797-33895076	HepG2	liver:	n/a	n/a
2	ATF1	chr17:33894739-33895254	K562	blood:	n/a	n/a
3	ATF2	chr17:33894688-33895260	GM12878	blood:	n/a	n/a
4	ATF3	chr17:33894830-33895140	GM12878	blood:	n/a	chr17:33894894-33894903 chr17:33895066-33895086 chr17:33895005-33895018
5	ATF3	chr17:33894712-33895356	GM12878	blood:	n/a	chr17:33894894-33894903 chr17:33895066-33895086 chr17:33895005-33895018
6	ATF3	chr17:33894741-33895265	H1-hESC	embryonic stem cell:	n/a	chr17:33894894-33894903 chr17:33895066-33895086 chr17:33895005-33895018
7	ATF3	chr17:33894730-33895257	K562	blood:	n/a	chr17:33894894-33894903 chr17:33895066-33895086 chr17:33895005-33895018
8	ATF3	chr17:33894741-33895346	H1-hESC	embryonic stem cell:	n/a	chr17:33894894-33894903 chr17:33895066-33895086 chr17:33895005-33895018
9	ATF3	chr17:33894727-33895300	HepG2	liver:	n/a	chr17:33894894-33894903 chr17:33895066-33895086 chr17:33895005-33895018
10	ATF3	chr17:33894659-33895263	K562	blood:	n/a	chr17:33894894-33894903 chr17:33895066-33895086 chr17:33895005-33895018
11	ATF3	chr17:33894867-33895232	HepG2	liver:	n/a	chr17:33894894-33894903 chr17:33895066-33895086 chr17:33895005-33895018
12	BCL3	chr17:33894578-33895201	A549	lung:	n/a	chr17:33894895-33894904
13	BCL3	chr17:33894584-33895469	A549	lung:	n/a	chr17:33894895-33894904
14	BCLAF1	chr17:33894579-33895030	GM12878	blood:	n/a	chr17:33894895-33894904
15	BCLAF1	chr17:33894641-33895340	GM12878	blood:	n/a	chr17:33894895-33894904
16	BHLHE40	chr17:33894722-33895310	K562	blood:	n/a	n/a
17	BRCA1	chr17:33894794-33895731	Hela-S3	cervix:	n/a	n/a
18	BRCA1	chr17:33894927-33895241	HepG2	liver:	n/a	n/a
19	CBX3	chr17:33894617-33895169	K562	blood:	n/a	n/a
20	CCNT2	chr17:33894758-33895341	K562	blood:	n/a	chr17:33894894-33894903
21	CEBPB	chr17:33894766-33895866	IMR90	lung:	n/a	chr17:33895695-33895706 chr17:33895027-33895035
22	CEBPB	chr17:33893396-33893701	K562	blood:	n/a	n/a
23	CEBPB	chr17:33894770-33895028	A549	lung:	n/a	n/a
24	CEBPB	chr17:33894798-33895255	Hela-S3	cervix:	n/a	chr17:33895027-33895035
25	CEBPB	chr17:33894797-33895039	HepG2	liver:	n/a	chr17:33895027-33895035
26	CEBPD	chr17:33894753-33895210	HepG2	liver:	n/a	n/a
27	CHD1	chr17:33894704-33894944	H1-hESC	embryonic stem cell:	n/a	n/a
28	CHD2	chr17:33894745-33895274	H1-hESC	embryonic stem cell:	n/a	n/a
29	CHD2	chr17:33894767-33895404	HepG2	liver:	n/a	n/a
30	CHD2	chr17:33894708-33895421	Hela-S3	cervix:	n/a	n/a
31	CHD2	chr17:33894715-33895437	GM12878	blood:	n/a	n/a
32	CHD2	chr17:33894697-33895536	K562	blood:	n/a	n/a
33	CREB1	chr17:33894634-33895325	H1-hESC	embryonic stem cell:	n/a	n/a
34	CREB1	chr17:33894612-33895412	HepG2	liver:	n/a	n/a
35	CREB1	chr17:33894626-33895421	GM12878	blood:	n/a	n/a
36	CREB1	chr17:33894536-33895455	HepG2	liver:	n/a	n/a
37	CREB1	chr17:33894735-33895284	A549	lung:	n/a	n/a
38	CREB1	chr17:33894697-33895343	K562	blood:	n/a	n/a
39	CREB1	chr17:33894691-33895294	ECC-1	luminal epithelium:	n/a	n/a
40	CREB1	chr17:33894683-33895362	ECC-1	luminal epithelium:	n/a	n/a
41	CREB1	chr17:33894585-33895414	H1-hESC	embryonic stem cell:	n/a	n/a
42	CREB1	chr17:33894563-33895435	K562	blood:	n/a	n/a
43	CREB1	chr17:33894662-33895297	A549	lung:	n/a	n/a
44	CREB1	chr17:33894520-33895896	GM12878	blood:	n/a	n/a
45	CTCF	chr17:33894950-33895145	Spleen_OC	spleen:	n/a	chr17:33895036-33895049
46	CTCF	chr17:33894668-33895378	K562	blood:	n/a	chr17:33895036-33895049
47	CTCF	chr17:33894953-33895120	GM12878	blood:	n/a	chr17:33895036-33895049
48	CTCF	chr17:33894456-33894524	Spleen_OC	spleen:	n/a	n/a
49	CUX1	chr17:33894756-33895077	K562	blood:	n/a	n/a
50	E2F4	chr17:33894609-33895314	MCF10A-Er-Src	breast:	n/a	chr17:33894894-33894906 chr17:33895027-33895036 chr17:33894894-33894903

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:33894952-33895002	HMEC	breast:	n/a
2	chr17:33894630-33894680	NHBE	bronchial:	n/a
3	chr17:33894952-33895002	NH-A	brain:	n/a
4	chr17:33894867-33894917	K562	blood:	n/a
5	chr17:33892241-33892291	AG04449	skin:	fetal
6	chr17:33892241-33892291	PANC-1	pancreas:	n/a
7	chr17:33894630-33894680	PANC-1	pancreas:	n/a
8	chr17:33894952-33895002	AG04449	skin:	fetal
9	chr17:33894952-33895002	NHDF-neo	bronchial:	n/a
10	chr17:33894952-33895002	HEK293	kidney:	embryo
11	chr17:33894970-33895020	Hepatocyte	liver:	n/a
12	chr17:33894952-33895002	GM12878	blood:	n/a
13	chr17:33894952-33895002	SKMC	muscle:	n/a
14	chr17:33892241-33892291	A549	lung:	n/a
15	chr17:33894952-33895002	ovcar-3	ovarian:	n/a
16	chr17:33894970-33895020	SK-N-SH_RA	brain:	n/a
17	chr17:33894867-33894917	PrEC	prostate:	n/a
18	chr17:33892241-33892291	SK-N-MC	brain:	n/a
19	chr17:33894970-33895020	HCPEpiC	choroid plexus:	n/a
20	chr17:33894952-33895002	HUVEC	blood vessel:	n/a
21	chr17:33892241-33892291	U87	brain:	n/a
22	chr17:33894867-33894917	HRPEpiC	eye:	n/a
23	chr17:33894952-33895002	HPAEpiC	pulmonary alveolar:	n/a
24	chr17:33894952-33895002	Jurkat	blood:	n/a
25	chr17:33894867-33894917	HIPEpiC	eye:	n/a
26	chr17:33894970-33895020	IMR90	lung:	fetal
27	chr17:33894867-33894917	Hepatocyte	liver:	n/a
28	chr17:33892241-33892291	T-47D	breast:	n/a
29	chr17:33894867-33894917	Hela-S3	cervix:	n/a
30	chr17:33894867-33894917	NT2-D1	testis:	n/a
31	chr17:33894970-33895020	PFSK-1	brain:	n/a
32	chr17:33894867-33894917	T-47D	breast:	n/a
33	chr17:33894970-33895020	HAEpiC	amniotic membrane:	n/a
34	chr17:33894630-33894680	NHDF-neo	bronchial:	n/a
35	chr17:33894867-33894917	SK-N-MC	brain:	n/a
36	chr17:33894630-33894680	ProgFib	skin:	n/a
37	chr17:33894630-33894680	RPTEC	kidney:	n/a
38	chr17:33892241-33892291	NHBE	bronchial:	n/a
39	chr17:33892241-33892291	PrEC	prostate:	n/a
40	chr17:33892241-33892291	AG09309	skin:	n/a
41	chr17:33894970-33895020	ProgFib	skin:	n/a
42	chr17:33894970-33895020	NH-A	brain:	n/a
43	chr17:33894970-33895020	T-47D	breast:	n/a
44	chr17:33894952-33895002	A549	lung:	n/a
45	chr17:33894867-33894917	HUVEC	blood vessel:	n/a
46	chr17:33894970-33895020	GM06990	blood:	n/a
47	chr17:33894952-33895002	ProgFib	skin:	n/a
48	chr17:33894630-33894680	HL-60	blood:	n/a
49	chr17:33894630-33894680	HEEpiC	esophagus:	n/a
50	chr17:33894630-33894680	PFSK-1	brain:	n/a

No.	Distal block	Cell Line	Cell type
1	chr17:33894766..33896836-chr17:33913022..33916399,3	MCF-7	breast:
2	chr17:33886372..33890944-chr17:33891247..33895229,11	K562	blood:
3	chr1:154946171..154947021-chr17:33894708..33895221,2	Hela-S3	cervix:
4	chr17:33893761..33897248-chr17:33899377..33902990,5	MCF-7	breast:
5	chr17:33893824..33895905-chr17:56735136..56737065,2	MCF-7	breast:
6	chr17:33893246..33896592-chr17:33904977..33907170,4	MCF-7	breast:
7	chr17:33892195..33894200-chr17:34134782..34137507,2	K562	blood:
8	chr17:33891678..33894359-chr17:33894876..33897610,2	MCF-7	breast:
9	chr17:33891678..33894359-chr17:33894876..33897610,2	MCF-7	breast:
10	chr11:62323606..62324603-chr17:33894795..33895615,2	Hela-S3	cervix:
11	chr17:33891810..33896606-chr17:33903023..33907452,11	MCF-7	breast:
12	chr17:33890829..33892673-chr17:33894883..33896486,2	MCF-7	breast:

Variant related genes	Relation type
ENSG00000267625	TF binding region
ENSG00000242660	TF binding region
ENSG00000267321	TF binding region
ENSG00000267625	CpG island
ENSG00000242660	CpG island
ENSG00000267321	CpG island
ENSG00000172660	chromatin interactions
ENSG00000207297	chromatin interactions
ENSG00000202077	chromatin interactions
ENSG00000242660	chromatin interactions
ENSG00000267625	chromatin interactions
ENSG00000267321	chromatin interactions
ENSG00000267578	chromatin interactions
ENSG00000006125	chromatin interactions
ENSG00000124942	chromatin interactions
ENSG00000160691	chromatin interactions
ENSG00000108733	chromatin interactions

Extended variants
information (count: 120 )
Associated
traits (count: 115 )

Variant overlapped rSNPs/rCNVs (count:120 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs537598477	chr17:33891879-33891880	Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
2	rs115338875	chr17:33892000-33892001	Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
3	rs561508568	chr17:33892003-33892004	Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
4	rs185239456	chr17:33892034-33892035	Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
5	rs540397291	chr17:33892066-33892067	Weak transcription Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
6	rs2840044	chr17:33892068-33892069	Weak transcription Flanking Active TSS	Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance disease
7	rs577080163	chr17:33892073-33892074	Weak transcription Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
8	rs321601	chr17:33892087-33892088	Weak transcription Flanking Active TSS	Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
9	rs189611868	chr17:33892098-33892099	Weak transcription Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
10	rs535032601	chr17:33892107-33892108	Weak transcription Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
11	rs181820483	chr17:33892122-33892123	Weak transcription Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
12	rs148250738	chr17:33892154-33892155	Weak transcription Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
13	rs116874976	chr17:33892242-33892243	Weak transcription Enhancers	CpG island Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
14	rs530109847	chr17:33892253-33892254	Weak transcription Enhancers	CpG island Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
15	rs547186905	chr17:33892267-33892268	Weak transcription Enhancers	CpG island Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
16	rs566909160	chr17:33892291-33892292	Weak transcription Enhancers	CpG island Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
17	rs532842985	chr17:33892310-33892311	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
18	rs577948378	chr17:33892331-33892332	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
19	rs563411750	chr17:33892388-33892389	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
20	rs568551287	chr17:33892414-33892415	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
21	rs141280362	chr17:33892465-33892466	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
22	rs150635548	chr17:33892489-33892490	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
23	rs567839983	chr17:33892524-33892525	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
24	rs57092803	chr17:33892525-33892526	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
25	rs116710698	chr17:33892538-33892539	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
26	rs186856488	chr17:33892543-33892544	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
27	rs576919779	chr17:33892575-33892576	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
28	rs529022536	chr17:33892620-33892621	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
29	rs112288537	chr17:33892696-33892697	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
30	rs191644245	chr17:33892702-33892703	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
31	rs146304524	chr17:33892748-33892749	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
32	rs9891887	chr17:33892778-33892779	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
33	rs573904368	chr17:33892818-33892819	Weak transcription Enhancers	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
34	rs561232199	chr17:33892834-33892835	Weak transcription Enhancers	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
35	rs139733581	chr17:33892875-33892876	Weak transcription Enhancers	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
36	rs540320993	chr17:33892884-33892885	Weak transcription Enhancers	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
37	rs560783557	chr17:33892899-33892900	Weak transcription Enhancers	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
38	rs532585314	chr17:33892933-33892934	Weak transcription Enhancers	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
39	rs1968578	chr17:33892949-33892950	Weak transcription Enhancers	TF binding region Chromatin interactive region	7 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs572888782	chr17:33892960-33892961	Weak transcription Enhancers	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
41	rs145308443	chr17:33892987-33892988	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
42	rs183047840	chr17:33893095-33893096	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
43	rs547800677	chr17:33893130-33893131	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
44	rs567924970	chr17:33893131-33893132	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
45	rs547277314	chr17:33893166-33893167	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
46	rs533892700	chr17:33893199-33893200	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
47	rs17550716	chr17:33893208-33893209	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
48	rs570667456	chr17:33893234-33893235	Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
49	rs539241558	chr17:33893324-33893325	Weak transcription Enhancers	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
50	rs186744262	chr17:33893373-33893374	Weak transcription Enhancers	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:115)

Disease	PMID	Source
Melanoma	18172304	CNVD
Wilms tumour	21544195	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Ewing''s sarcoma	21437220	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21781307	CNVD
Colorectal cancer	21645411	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Medulloblastoma	21979893	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	17603634	CNVD
T-cell lymphomas	19863542	CNVD
Cancer	16751803	CNVD
Chordoma	21602918	CNVD
Neurofibromatosis	20686819	CNVD
Peripheral nerve sheath tumors	20686819	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Cancer	21499728	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	17897457	CNVD
Neuroblastoma	17327916	CNVD
Breast cancer	21264507	CNVD
Endometrial cancer	22040021	CNVD
Neuroblastoma	21484798	CNVD
Breast cancer	22028636	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute myeloid leukemia	20724749	CNVD
Breast cancer	21858162	CNVD
Breast cancer	16397240	CNVD
Myxofibrosarcoma	16751306	CNVD
lymphocytic leukemia	21291569	CNVD
Breast cancer	17001317	CNVD
Breast cancer	17157792	CNVD
Bladder cancer	19088036	CNVD
Gastric cancer	17167181	CNVD
Breast cancer	19287154	CNVD
Leukemia	20874852	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Neuroblastoma	18664255	CNVD
Neuroblastoma	17533364	CNVD
Human rectal carcinomas	16397240	CNVD
Meningioma	19431122	CNVD
Neurocytoma	17123091	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Lung cancer	21911935	CNVD
Breast cancer	22048815	CNVD
Cervical cancer	21062161	CNVD
Colorectal cancer	22860045	CNVD
Ductal carcinoma	18381933	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16417655	CNVD
Renal cysts	20603712	CNVD
Epilepsy	21858020	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Autism	20587423	CNVD
Renal cysts	20587423	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Ovarian cancer	20844748	CNVD
Mayer-Rokitansky-Kuster-Hauser syndrome	19889212	CNVD
Endometrial cancer	23636398	CNVD
Urothelial cell carcinoma	18451213	CNVD
Gastric cancer	24379144	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16785998	CNVD
Breast cancer	17850661	CNVD
Primary lung adenocarcinoma	16799635	CNVD
HIV/AIDS	18848619	CNVD
Rheumatoid arthritis	19220326	CNVD
Rheumatoid arthritis	18848619	CNVD
Systemic lupus erythematosus	19220326	CNVD
Systemic lupus erythematosus	18848619	CNVD
Type 1 diabetes	19220326	CNVD
HIV/AIDS	17330138	CNVD
Basal cell lymphoma	17053054	CNVD
Autism	19955444	CNVD
Schizophrenia	19955444	CNVD
Acute monocytic leukemia	16498392	CNVD
Breast cancer	20409316	CNVD
Myelodysplastic syndrome	18663149	CNVD
Breast cancer	17457667	CNVD
Breast cancer	16951389	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Lung cancer	19153074	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21785460	CNVD
Breast cancer	20932292	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Adrenocortical carcinoma	18281524	CNVD
Lung cancer	21569311	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:195 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:33888600-33894200	Weak transcription	Primary hematopoietic stem cells	blood
2	chr17:33889600-33894000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
3	chr17:33889800-33894000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
4	chr17:33890600-33892200	Flanking Active TSS	K562	blood
5	chr17:33892200-33893600	Enhancers	K562	blood
6	chr17:33893600-33894200	Flanking Active TSS	K562	blood
7	chr17:33893800-33894000	Enhancers	Dnd41	blood
8	chr17:33894000-33894200	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
9	chr17:33894000-33894200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
10	chr17:33894000-33894200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
11	chr17:33894000-33894200	Bivalent Enhancer	Fetal Intestine Small	intestine
12	chr17:33894000-33894200	Enhancers	Skeletal Muscle Male	skeletal muscle
13	chr17:33894000-33894400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
14	chr17:33894000-33894400	Flanking Active TSS	Dnd41	blood
15	chr17:33894000-33895400	Active TSS	Primary T helper cells PMA-I stimulated	--
16	chr17:33894000-33895400	Active TSS	Fetal Lung	lung
17	chr17:33894000-33895800	Active TSS	Fetal Kidney	kidney
18	chr17:33894000-33896400	Active TSS	ES-I3 Cell Line	embryonic stem cell
19	chr17:33894000-33896400	Active TSS	H9 Cell Line	embryonic stem cell
20	chr17:33894000-33896400	Active TSS	iPS-18 Cell Line	embryonic stem cell
21	chr17:33894000-33897000	Active TSS	HUES6 Cell Line	embryonic stem cell
22	chr17:33894200-33894400	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
23	chr17:33894200-33894400	Enhancers	Primary monocytes fromperipheralblood	blood
24	chr17:33894200-33894400	Enhancers	Primary B cells from peripheral blood	blood
25	chr17:33894200-33894400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
26	chr17:33894200-33894400	Enhancers	Primary hematopoietic stem cells	blood
27	chr17:33894200-33894400	Enhancers	Primary T helper cells fromperipheralblood	blood
28	chr17:33894200-33894400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
29	chr17:33894200-33894400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
30	chr17:33894200-33894400	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
31	chr17:33894200-33894400	Flanking Active TSS	Brain Germinal Matrix	brain
32	chr17:33894200-33894400	Enhancers	Duodenum Mucosa	Duodenum
33	chr17:33894200-33894400	Bivalent/Poised TSS	Fetal Adrenal Gland	Adrenal Gland
34	chr17:33894200-33894400	Enhancers	Fetal Intestine Large	intestine
35	chr17:33894200-33894400	Enhancers	Fetal Muscle Trunk	muscle
36	chr17:33894200-33894400	Enhancers	Placenta	Placenta
37	chr17:33894200-33894400	Enhancers	Pancreas	Pancrea
38	chr17:33894200-33894400	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
39	chr17:33894200-33894400	Active TSS	Skeletal Muscle Female	skeletal muscle
40	chr17:33894200-33894400	Flanking Active TSS	Stomach Smooth Muscle	stomach
41	chr17:33894200-33894600	Flanking Active TSS	Primary B cells from cord blood	blood
42	chr17:33894200-33894600	Enhancers	Liver	Liver
43	chr17:33894200-33894600	Enhancers	Brain Cingulate Gyrus	brain
44	chr17:33894200-33894600	Enhancers	Left Ventricle	heart
45	chr17:33894200-33894600	Enhancers	Lung	lung
46	chr17:33894200-33894600	Enhancers	Spleen	Spleen
47	chr17:33894200-33894600	Enhancers	Monocytes-CD14+_RO01746	blood
48	chr17:33894200-33894800	Active TSS	Primary hematopoietic stem cells short term culture	blood
49	chr17:33894200-33895200	Active TSS	Adipose Nuclei	Adipose
50	chr17:33894200-33895400	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links